Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
18.58
+1.57 (9.26%)
At close: Jun 6, 2025, 4:00 PM
18.64
+0.07 (0.35%)
Pre-market: Jun 9, 2025, 4:59 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Genetic Medicines
63.52M
Log In
Log In
Log In
Log In
Upgrade
Genetic Medicines Growth
-83.18%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
63.52M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-83.18%
Log In
Log In
Log In
Log In
Upgrade